⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Lincoln Pharmaceuticals LimitedLINCOLN

Lincoln Pharmaceuticals Limited is an Indian pharmaceutical company involved in the manufacturing and distribution of generic drugs.

Key productsGeneric drugs, APIs (Active Pharmaceutical Ingredients)
GeographyIndia, exports to Southeast Asia
CompetitorsDr Reddy's Laboratories, Cipla

AI-generated overview — verify before relying on it.

Net institutional flow

+₹10 Cr

Institutional buyers

1 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Rs 1.80 Per Share

ex 2025-09-12

Competitive landscape — the read

vs most-traded names · ALL
1M3M6M1Y2YAll
Institutional money is backing LINCOLN hardest (+₹10 Cr net). LINCOLN leads this set on institutional accumulation.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1LINCOLNThis+₹10 Cr5————
2ATALREAL+₹7.2 Cr154————
3MOBIKWIK+₹0.1 Cr83————
4QUADFUTURE+₹0 Cr134————
5MTNL+₹0 Cr2————
6GATECH+₹0 Cr8————
7IRMENERGY−₹2.2 Cr328————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — LINCOLN day by day

1M3M6M1Y2YAll
  1. 2026-04-29BulkSELL · ₹14.8 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  2. 2026-04-29BulkBUY · ₹14.7 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  3. 2026-04-29BulkSELL · ₹7.6 CrQE SECURITIES LLP
  4. 2026-04-29BulkBUY · ₹7.7 CrQE SECURITIES LLP
  5. 2026-04-29NetDay net +₹0.1 Cr
  6. 2026-02-12BulkBUY · ₹10 CrGREENX WEALTH MULTIHORIZONS OPPORTUNITY FUND
  7. 2026-02-12NetDay net +₹10 Cr
  8. 2025-09-12ActionDividend - Rs 1.80 Per ShareDividend
  9. 2025-08-07BulkSELL · ₹6.3 CrIRAGE BROKING SERVICES LLP
  10. 2025-08-07BulkBUY · ₹8.3 CrIRAGE BROKING SERVICES LLP
  11. 2025-08-07BulkBUY · ₹9.7 CrMUSIGMA SECURITIES
  12. 2025-08-07BulkSELL · ₹9.7 CrMUSIGMA SECURITIES
  13. 2025-08-07BulkBUY · ₹16.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  14. 2025-08-07BulkSELL · ₹16.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  15. 2025-08-07NetDay net +₹2 Cr
  16. 2024-12-05BulkSELL · ₹11.4 CrHITESH BABUBHAI MANGUKIYA
  17. 2024-12-05BulkBUY · ₹12.9 CrHITESH BABUBHAI MANGUKIYA
  18. 2024-12-05NetDay net +₹1.5 Cr
  19. 2024-12-04BulkBUY · ₹14.2 CrHITESH BABUBHAI MANGUKIYA
  20. 2024-12-04BulkSELL · ₹14.6 CrHITESH BABUBHAI MANGUKIYA
  21. 2024-12-04NetDay net −₹0.4 Cr
  22. 2024-09-13ActionDividend - Rs 1.80 Per ShareDividend
  23. 2024-09-05BulkBUY · ₹10.3 CrGRAVITON RESEARCH CAPITAL LLP
  24. 2024-09-05BulkSELL · ₹10.3 CrGRAVITON RESEARCH CAPITAL LLP
  25. 2024-09-05NetDay net −₹0 Cr

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for LINCOLN yet.

Bulk & block deals

1M3M6M1Y2YAll

17 deals · 2024-09-05 → 2026-04-29

DateCounterpartyTypeSideValue
2026-04-29NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹14.8 Cr
2026-04-29NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹14.7 Cr
2026-04-29QE SECURITIES LLPProp / churnSELL₹7.6 Cr
2026-04-29QE SECURITIES LLPProp / churnBUY₹7.7 Cr
2026-02-12GREENX WEALTH MULTIHORIZONS OPPORTUNITY FUNDInstitutionBUY₹10 Cr
2025-08-07IRAGE BROKING SERVICES LLPProp / churnSELL₹6.3 Cr
2025-08-07IRAGE BROKING SERVICES LLPProp / churnBUY₹8.3 Cr
2025-08-07MUSIGMA SECURITIESProp / churnBUY₹9.7 Cr
2025-08-07MUSIGMA SECURITIESProp / churnSELL₹9.7 Cr
2025-08-07NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹16.5 Cr

17 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on LINCOLN

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.